DK1797099T3 - Piperidinylamino-thieno[2,3-D]pyrimidinforbindelser - Google Patents

Piperidinylamino-thieno[2,3-D]pyrimidinforbindelser

Info

Publication number: DK1797099T3
Authority: DK; Denmark
Prior art keywords: piperidinylamino; thieno; pyrimidine compounds; pyrimidine; compounds
Prior art date: 2004-09-23

Application number

DK05800014.2T

Other languages

English (en)

Inventor

Dongli Chen

Anurag Sharadendu

Srinivasa Rao Cheruku

Dale S Dhanoa

Oren Becker

Silvia Noiman

Sekar Reddy Alla

Rosa E Melendez

Yael Marantz

Sharon Shacham

Alexander Heifetz

Boaz Inbal

Venkitasamy Kesavan

Shay Bar-Haim

Original Assignee

Epix Delaware Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-09-23

Filing date

2005-09-23

Publication date

2010-11-29

2004-09-23 Priority claimed from US10/947,995 external-priority patent/US20050222175A1/en

2005-09-23 Application filed by Epix Delaware Inc filed Critical Epix Delaware Inc

2010-11-29 Application granted granted Critical

2010-11-29 Publication of DK1797099T3 publication Critical patent/DK1797099T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Endocrinology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Pain & Pain Management (AREA)
Pulmonology (AREA)
Diabetes (AREA)
Reproductive Health (AREA)
Psychology (AREA)
Psychiatry (AREA)
Gynecology & Obstetrics (AREA)
Rheumatology (AREA)
Anesthesiology (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Physical Education & Sports Medicine (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

DK05800014.2T 2004-09-23 2005-09-23 Piperidinylamino-thieno[2,3-D]pyrimidinforbindelser DK1797099T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US10/947,995 US20050222175A1 (en)	2004-03-31	2004-09-23	New piperidinylamino-thieno[2,3-D] pyrimidine compounds
US11/075,565 US7612078B2 (en)	2003-03-31	2005-03-08	Piperidinylamino-thieno[2,3-D] pyrimidine compounds
PCT/US2005/034862 WO2006034511A1 (en)	2004-09-23	2005-09-23	Piperidinylamino-thieno[2,3-d] pyrimidine compounds

Publications (1)

Publication Number	Publication Date
DK1797099T3 true DK1797099T3 (da)	2010-11-29

Family

ID=35528225

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK05800014.2T DK1797099T3 (da)	2004-09-23	2005-09-23	Piperidinylamino-thieno[2,3-D]pyrimidinforbindelser

Country Status (21)

Country	Link
US (2)	US7612078B2 (da)
EP (1)	EP1797099B1 (da)
JP (1)	JP2008514643A (da)
KR (1)	KR20070057970A (da)
CN (1)	CN101048412A (da)
AR (1)	AR054982A1 (da)
AT (1)	ATE477257T1 (da)
AU (1)	AU2005287898A1 (da)
BR (1)	BRPI0515530A (da)
CA (1)	CA2581175A1 (da)
DE (1)	DE602005022897D1 (da)
DK (1)	DK1797099T3 (da)
HR (1)	HRP20100607T1 (da)
IL (1)	IL182099A0 (da)
MX (1)	MX2007003026A (da)
NO (1)	NO20072037L (da)
NZ (1)	NZ553886A (da)
PL (1)	PL1797099T3 (da)
PT (1)	PT1797099E (da)
TW (1)	TW200628472A (da)
WO (1)	WO2006034511A1 (da)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20050222175A1 (en) *	2004-03-31	2005-10-06	Dhanoa Dale S	New piperidinylamino-thieno[2,3-D] pyrimidine compounds
US7488736B2 (en) *	2004-05-17	2009-02-10	Epix Delaware, Inc.	Thienopyridinone compounds and methods of treatment
US7407966B2 (en) *	2004-10-07	2008-08-05	Epix Delaware, Inc.	Thienopyridinone compounds and methods of treatment
US7576211B2 (en) *	2004-09-30	2009-08-18	Epix Delaware, Inc.	Synthesis of thienopyridinone compounds and related intermediates
US7598265B2 (en) *	2004-09-30	2009-10-06	Epix Delaware, Inc.	Compositions and methods for treating CNS disorders
US7576080B2 (en) *	2004-12-23	2009-08-18	Memory Pharmaceuticals Corporation	Certain thienopyrimidine derivatives as phosphodiesterase 10 inhibitors
CA2595607C (en) *	2005-01-25	2014-07-15	Epix Delaware, Inc.	Substituted arylamine compounds and their use as 5-ht6 modulators
WO2007056214A2 (en) *	2005-11-02	2007-05-18	Cytovia, Inc	N-alkyl-n-aryl-thienopyrimidin-r-amines and uses thereof
WO2007056208A2 (en) *	2005-11-02	2007-05-18	Cytovia, Inc.	N-arylalkyl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof
US20070099877A1 (en) *	2005-11-02	2007-05-03	Cytovia, Inc.	N-aryl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof
US7939661B2 (en) *	2006-09-11	2011-05-10	Hoffman-La Roche Inc.	Pyridine, quinoline and pyrimidine derivatives
WO2008061966A2 (en) *	2006-11-22	2008-05-29	Boehringer Ingelheim International Gmbh	New use of flibanserin
WO2008061968A1 (en) *	2006-11-22	2008-05-29	Boehringer Ingelheim International Gmbh	Benzimidazolone derivates in the treatment of pulmonary arterial hypertension
JP2010538078A (ja) *	2007-09-04	2010-12-09	エピックスデラウェア，インコーポレイテッド	線維症を治療するためのピペリジニルアミノ−チエノ［２，３−ｄ］ピリミジン化合物
WO2010065743A2 (en) *	2008-12-03	2010-06-10	Nanotherapeutics, Inc.	Bicyclic compounds and methods of making and using same
US8618116B2 (en) *	2009-08-03	2013-12-31	Daljit Singh Dhanoa	Deuterium-enriched pyrimidine compounds and derivatives
CN103119047B (zh)	2010-07-23	2016-06-15	哈佛大学校长及研究员协会	三环类蛋白酶体活性增强化合物
WO2012154009A2 (ko) *	2011-05-12	2012-11-15	한국화학연구원	티에노피리미딘 유도체， 이의 약학적으로 허용가능한 이의 제조방법 및 이를 유효성분으로 함유하는 당뇨 관련 질환의 또는 치료용 약학적 조성물
CA2861464C (en)	2012-01-25	2018-03-06	Proteostasis Therapeutics, Inc.	Proteasome activity modulating tricyclic compounds
CN103467596A (zh) *	2012-06-06	2013-12-25	北京大学	一个治疗肺动脉高压的新靶点
WO2014164543A1 (en) *	2013-03-13	2014-10-09	The Regents Of The University Of Michigan	Compositions comprising thienopyrimidine and thienopyridine compounds and methods of use thereof
USRE49687E1 (en)	2014-09-09	2023-10-10	The Regents Of The University Of Michigan	Thienopyrimidine and thienopyridine compounds and methods of use thereof
CN104592248A (zh) *	2014-12-31	2015-05-06	芜湖杨燕制药有限公司	一种4-氯-6-取代噻吩并[2,3-d]嘧啶化合物的制备方法
TWI703150B (zh) *	2015-06-04	2020-09-01	美商庫拉腫瘤技術股份有限公司	用於抑制ｍｅｎｉｎ及ｍｌｌ蛋白之交互作用的方法及組合物
WO2016197027A1 (en)	2015-06-04	2016-12-08	Kura Oncology, Inc.	Methods and compositions for inhibiting the interaction of menin with mll proteins
JP6919977B2 (ja)	2016-03-16	2021-08-18	クラオンコロジー，インク．	メニン−ｍｌｌの置換された阻害剤及びその使用方法
CA3015845A1 (en)	2016-03-16	2017-09-21	Kura Oncology, Inc.	Bridged bicyclic inhibitors of menin-mll and methods of use
US12084462B2 (en)	2016-09-14	2024-09-10	Janssen Pharmaceutica Nv	Spiro bicyclic inhibitors of menin-MLL interaction
HUE053907T2 (hu)	2016-09-14	2021-07-28	Janssen Pharmaceutica Nv	A menin-MLL kölcsönhatás spiro-biciklusos inhibitorai
JP7033141B2 (ja) *	2016-09-14	2022-03-09	ヤンセンファーマシューティカエヌ．ベー．	メニン－ｍｌｌ相互作用の縮合二環式阻害剤
CA3044739A1 (en)	2016-12-15	2018-06-21	Janssen Pharmaceutica Nv	Azepane inhibitors of menin-mll interaction
CN110691779B (zh)	2017-03-24	2023-10-10	库拉肿瘤学公司	治疗血液系统恶性肿瘤和尤因肉瘤的方法
WO2018226976A1 (en)	2017-06-08	2018-12-13	Kura Oncology, Inc.	Methods and compositions for inhibiting the interaction of menin with mll proteins
US11649251B2 (en)	2017-09-20	2023-05-16	Kura Oncology, Inc.	Substituted inhibitors of menin-MLL and methods of use
US11396517B1 (en)	2017-12-20	2022-07-26	Janssen Pharmaceutica Nv	Exo-aza spiro inhibitors of menin-MLL interaction
CN110075109B (zh) *	2019-03-28	2021-07-27	中国人民解放军军事科学院军事医学研究院	一种促进干细胞因子合成和分泌的化合物及其用途
CN114560843B (zh) *	2022-04-02	2023-04-18	河南维诺生物科技有限公司	一种作为荧光探针的化合物及其合成方法和应用

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3069412A (en)	1958-08-15	1962-12-18	Fmc Corp	N-aminoazetidine and preparation thereof
CA933923A (en)	1969-12-19	1973-09-18	Eichenberger Kurt	Process for the manufacture of new thiopyranes
GB1570494A (en)	1975-11-28	1980-07-02	Ici Ltd	Thienopyrimidine derivatives and their use as pesticides
DE2925175A1 (de)	1979-06-22	1981-01-08	Basf Ag	Verfahren zur herstellung von isatosaeureanhydriden
IT1203323B (it)	1987-02-02	1989-02-15	Hoechst Italia Spa	Additivo fotoattivatore per composizioni polimeriche costituito dal sale metallico di una cera ossidata
US5236917A (en)	1989-05-04	1993-08-17	Sterling Winthrop Inc.	Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof
DE4008726A1 (de)	1990-03-19	1991-09-26	Basf Ag	Thieno(2,3-d)pyrimidinderivate
US5155115A (en)	1991-03-12	1992-10-13	Kyowa Hakko Kogyo Co., Ltd.	Thienopyridine derivatives
US5219864A (en)	1991-03-12	1993-06-15	Kyowa Hakko Kogyo Co., Ltd.	Thienopyridine derivatives
US5227387A (en)	1991-09-03	1993-07-13	Dowelanco	Quinoline nematicidal method
DE4138820A1 (de)	1991-11-26	1993-05-27	Basf Ag	Chinolin-3-carbonsaeureamide, deren herstellung und verwendung
DE4208254A1 (de)	1992-03-14	1993-09-16	Hoechst Ag	Substituierte pyrimidine, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel und fungizid
DE4227747A1 (de)	1992-08-21	1994-02-24	Basf Ag	Heteroaromatisch kondensierte Hydroxypyridoncarbonsäureamide, deren Herstellung und Verwendung
US5409948A (en)	1992-11-23	1995-04-25	The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services	Method for treating cognitive disorders with phenserine
JPH06239858A (ja)	1993-02-16	1994-08-30	Otsuka Pharmaceut Co Ltd	末梢血管拡張剤
GB9306460D0 (en)	1993-03-29	1993-05-19	Smithkline Beecham Plc	Novel compounds
TW449600B (en)	1994-04-19	2001-08-11	Takeda Chemical Industries Ltd	Condensed-ring thiophene derivatives, their production and use
JP3829879B2 (ja)	1994-05-18	2006-10-04	大正製薬株式会社	キノリンカルボン酸誘導体
GB2295387A (en)	1994-11-23	1996-05-29	Glaxo Inc	Quinazoline antagonists of alpha 1c adrenergic receptors
DE19636769A1 (de)	1996-09-10	1998-03-12	Basf Ag	3-Substituierte Pyrido [4',3':4,5]thieno[2,3-d]pyrimidin-Derivate, ihre Herstellung und Verwendung
DE19724980A1 (de)	1997-06-13	1998-12-17	Basf Ag	3-Substituierte 3,4-Dihydro-thieno[2,3-d]pyrimidin-Derivate, ihre Herstellung und Verwendung
JPH11130777A (ja)	1997-08-13	1999-05-18	Takeda Chem Ind Ltd	チエノピリジン誘導体、その中間体およびそれらの製造法
US6340759B1 (en)	1997-10-02	2002-01-22	Eisai Co., Ltd.	Fused pyridine derivatives
US6103903A (en)	1998-02-26	2000-08-15	Neurogen Corporation	4-(4-piperidylmethyhlamino) substituted heteroaryl fused pyridines: GABA brain receptor ligands
DE19815026A1 (de)	1998-04-03	1999-10-07	Hoechst Schering Agrevo Gmbh	Substituierte Piperidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel und Fungizide
US6232320B1 (en)	1998-06-04	2001-05-15	Abbott Laboratories	Cell adhesion-inhibiting antiinflammatory compounds
AU5259100A (en)	1999-04-28	2000-11-10	Respiratorius Ab	Medicament
SE9902987D0 (sv)	1999-08-24	1999-08-24	Astra Pharma Prod	Novel compounds
EP1229025A4 (en)	1999-10-01	2003-04-09	Japan Energy Corp	NEW QUINAZOLINE DERIVATIVES
EP1270568A1 (en)	2001-06-19	2003-01-02	Biofrontera Pharmaceuticals AG	1-methyl-4-(3-ethoxy-9h-thioxanthene-ylidene)-piperidine and its use as 5-HT2B and/or H1 antagonist
WO2003020728A1 (en)	2001-08-30	2003-03-13	Pharmacia & Upjohn Company	4-THIOXO-4,7-DIHYDRO-THIENO[2,3-b]PYRIDINE-5-CARBOTHIOAMIDES AS ANTIVIRAL AGENTS
MXPA03000145A (es)	2002-01-07	2003-07-15	Pfizer	Compuestos de oxo u oxi-piridina como moduladores de receptores 5-ht4.
WO2004034963A2 (en)	2002-05-17	2004-04-29	Eisai Co., Ltd.	Methods and compositions using cholinesterase inhibitors
US20040138238A1 (en)	2002-08-08	2004-07-15	Dhanoa Dale S.	Substituted aminopyrimidine compounds as neurokinin antagonists
WO2004017950A2 (en)	2002-08-22	2004-03-04	Piramed Limited	Phosphadidylinositol 3,5-biphosphate inhibitors as anti-viral agents
AU2003277215A1 (en)	2002-10-01	2004-04-23	Predix Pharmaceuticals Holdings, Inc.	Novel neurokinin antagonists and methods of use thereof
US7153858B2 (en)	2003-01-31	2006-12-26	Epix Delaware, Inc.	Arylpiperazinyl compounds
KR20060013370A (ko)	2003-03-31	2006-02-09	프레딕스 파마슈티컬스 홀딩즈, 인코포레이티드	신규한 피페리디닐아미노-티에노[2,3-ｄ]피리미딘 화합물
US20050222175A1 (en)	2004-03-31	2005-10-06	Dhanoa Dale S	New piperidinylamino-thieno[2,3-D] pyrimidine compounds
US7119205B2 (en)	2003-05-16	2006-10-10	Abbott Laboratories	Thienopyridones as AMPK activators for the treatment of diabetes and obesity
CA2532347C (en)	2003-07-25	2012-03-27	F. Hoffmann-La Roche Ag	Combination of mglur2 antagonist and ache inhibitor for treatment of acute and/or chronic neurological disorders
GB0322140D0 (en)	2003-09-22	2003-10-22	Pfizer Ltd	Combinations
WO2005049027A2 (en)	2003-11-03	2005-06-02	Probiodrug Ag	Combinations useful for the treatment of neuronal disorders
US7488736B2 (en)	2004-05-17	2009-02-10	Epix Delaware, Inc.	Thienopyridinone compounds and methods of treatment
US20060084806A1 (en)	2004-07-21	2006-04-20	Ramasubramanian Sridharan	Processes for the preparation of imidazo[1,2-a] pyridine derivatives
US7576211B2 (en)	2004-09-30	2009-08-18	Epix Delaware, Inc.	Synthesis of thienopyridinone compounds and related intermediates
US7598265B2 (en)	2004-09-30	2009-10-06	Epix Delaware, Inc.	Compositions and methods for treating CNS disorders
US7407966B2 (en)	2004-10-07	2008-08-05	Epix Delaware, Inc.	Thienopyridinone compounds and methods of treatment
CA2595607C (en)	2005-01-25	2014-07-15	Epix Delaware, Inc.	Substituted arylamine compounds and their use as 5-ht6 modulators
AU2006317689B2 (en)	2005-11-23	2013-07-25	Epix Delaware, Inc.	S1P receptor modulating compounds and use thereof

2005
- 2005-03-08 US US11/075,565 patent/US7612078B2/en not_active Expired - Fee Related
- 2005-09-23 WO PCT/US2005/034862 patent/WO2006034511A1/en active Application Filing
- 2005-09-23 MX MX2007003026A patent/MX2007003026A/es unknown
- 2005-09-23 BR BRPI0515530-4A patent/BRPI0515530A/pt not_active IP Right Cessation
- 2005-09-23 CA CA002581175A patent/CA2581175A1/en not_active Abandoned
- 2005-09-23 DK DK05800014.2T patent/DK1797099T3/da active
- 2005-09-23 NZ NZ553886A patent/NZ553886A/en unknown
- 2005-09-23 JP JP2007533765A patent/JP2008514643A/ja active Pending
- 2005-09-23 AU AU2005287898A patent/AU2005287898A1/en not_active Abandoned
- 2005-09-23 DE DE602005022897T patent/DE602005022897D1/de active Active
- 2005-09-23 CN CNA2005800360646A patent/CN101048412A/zh active Pending
- 2005-09-23 EP EP05800014A patent/EP1797099B1/en active Active
- 2005-09-23 PT PT05800014T patent/PT1797099E/pt unknown
- 2005-09-23 TW TW094133175A patent/TW200628472A/zh unknown
- 2005-09-23 PL PL05800014T patent/PL1797099T3/pl unknown
- 2005-09-23 AT AT05800014T patent/ATE477257T1/de active
- 2005-09-23 KR KR1020077009078A patent/KR20070057970A/ko not_active Application Discontinuation
- 2005-09-26 AR ARP050103996A patent/AR054982A1/es unknown
2007
- 2007-03-21 IL IL182099A patent/IL182099A0/en unknown
- 2007-04-20 NO NO20072037A patent/NO20072037L/no not_active Application Discontinuation
2009
- 2009-10-30 US US12/609,470 patent/US20100113485A1/en not_active Abandoned
2010
- 2010-11-11 HR HR20100607T patent/HRP20100607T1/hr unknown

Also Published As

Publication number	Publication date
BRPI0515530A (pt)	2008-07-29
US20100113485A1 (en)	2010-05-06
HRP20100607T1 (hr)	2011-03-31
EP1797099B1 (en)	2010-08-11
KR20070057970A (ko)	2007-06-07
NZ553886A (en)	2010-11-26
IL182099A0 (en)	2007-07-24
EP1797099A1 (en)	2007-06-20
NO20072037L (no)	2007-06-21
TW200628472A (en)	2006-08-16
AR054982A1 (es)	2007-08-01
ATE477257T1 (de)	2010-08-15
CN101048412A (zh)	2007-10-03
PL1797099T3 (pl)	2011-07-29
US7612078B2 (en)	2009-11-03
US20050222176A1 (en)	2005-10-06
PT1797099E (pt)	2010-11-18
CA2581175A1 (en)	2006-03-30
AU2005287898A1 (en)	2006-03-30
JP2008514643A (ja)	2008-05-08
DE602005022897D1 (de)	2010-09-23
MX2007003026A (es)	2007-12-04
WO2006034511A1 (en)	2006-03-30

Publication	Publication Date	Title
DK1797099T3 (da)	2010-11-29	Piperidinylamino-thieno[2,3-D]pyrimidinforbindelser
NO20161521L (no)	2007-04-26	Antivirale forbindelser
SMP200800029B (it)	2008-05-07	2-ammino-7,8-diidro-6h-pirido[4,3-d]pirimidin-5-oni
DK1824856T3 (da)	2014-01-27	2,4 (4,6)-pyrimidinderivater
IL181433A0 (en)	2007-07-04	Pyrimidine derivatives
DK1778702T3 (da)	2011-10-17	Antivirale forbindelser
ATE512960T1 (de)	2011-07-15	Pyrimidinderivate
HK1121062A1 (en)	2009-04-17	Pyrimidine compounds
EP1724267A4 (en)	2009-04-22	PYRIMIDINE DERIVATIVE
ZA200606974B (en)	2008-04-30	Substituted 1,2,3,4-tetrahydrolsoquinoline derivatives
GB0415364D0 (en)	2004-08-11	Pyrimidine derivatives
HK1104553A1 (en)	2008-01-18	Pyrimidine derivatives
SI1869056T1 (sl)	2011-02-28	Novi 5-substituirani 7-amino-(1,3)tiazolo(4,5-d) pirimidinski derivati
NL1030382A1 (nl)	2006-05-11	Gesubstitueerde N-sulfonylaminobenzyl-2-fenoxyaceetamide verbindingen.
IL172848A0 (en)	2006-06-11	2-substituted pyrimidines
DE602004021572D1 (de)	2009-07-30	SUBSTITUIERTE 8-PERFLUORO-6,7,8,9-TETRAHYDROPYRIMIDOi1,2-A PYRIMIDIN-4-ON-DERIVATE
BRPI0822239A2 (pt)	2015-06-30	Composto de pirazolo[1,5-a] pirimidina
GB0415367D0 (en)	2004-08-11	Pyrimidine derivatives
IS8015A (is)	2005-09-08	6-útskipt imídasópýrasín
AP2008004687A0 (en)	2008-12-31	Insecticidal methods using 4-amino-5-chloro-thieno(2,3-d)-pyrimidine compounds
IL172845A0 (en)	2006-06-11	2-substituted pyrimidines
ZA200701118B (en)	2008-06-25	Antiviral compounds
GB0424972D0 (en)	2004-12-15	Pyrimidine compounds
SE0400584D0 (sv)	2004-03-09	NNRTI Antivirals II
SE0400585D0 (sv)	2004-03-09	NNRTI Antivirals